期刊文献+

质子泵抑制剂市场前景看好 被引量:16

The market of proton pump inhibitors is in prospect
下载PDF
导出
摘要 目的:消化性溃疡是一种常见病和多发病,质子泵抑制剂是目前治疗消化性溃疡病抑制胃酸分泌最强的药物,质子泵抑制剂市场的现状和进展是人们关注的热点。方法:调查近年来长江流域上海、杭州、南京、武汉、成都和重庆六城市样本医院质子泵抑制剂品种用药金额、排序、份额、增长率及临床评价。结果:常用品种为奥美拉唑、泮托拉唑、埃索美拉唑、雷贝拉唑和兰索拉唑,其中用药金额名列第1是奥美拉唑,第2是泮托拉唑。结论:质子泵抑制剂市场前景看好。 Objective: Peptic ulcer is a common disease with high frequency. Proton pump lntnbitors are the most powerful drugs in inhibiting gastric acid secretion. The current status and prospect of the market of proton pump inhibitors have attracted more and more people. Methods: The market of proton pump inhibitors produced in Yangtze River Area was investigated in recent years. Shanghai, Hangzhou, Nanjing, Wuhan, Chengdu and Chongqing were selected as sample cities. The medication amount of proton pump inhibitors was investigated. The sort, share, rate and clinical efficacy of proton pmnp inhibitors were recorded. Results: Omeprazole, pantoprazole, esomeprazole, rabeprazole and lansoprazole were most frequently used. Among them, omeprazole ranked first, and the second was pantoprazole. Conclusion: Proton pump inhibitor market has a good prospect.
作者 徐红冰 归成
出处 《上海医药》 CAS 2010年第5期211-214,共4页 Shanghai Medical & Pharmaceutical Journal
关键词 质子泵抑制剂 奥美拉唑 泮托拉唑 埃索美拉唑 雷贝拉唑 兰索拉唑 proton pump inhibitors omeprazole pantoprazole esomeprazole rabeprazole lansoprazole
  • 相关文献

参考文献4

二级参考文献9

  • 1[2] Guticrre ZG, Palizas F, Doglio G, et al. Gastric intramucosal PH as a therapeutic index of tissue oxgenation in critically ill patients[J]. Lancet, 1992,339:195-199.
  • 2[3] Lanother pH, Ras E, Serra AJ, et al. Comparative efficacy of cimetidi ne, famotidine, ranitidine in postoperative stress ulcer[J]. Gastroenterology, 1991,100:1515-1520.
  • 3[4] Merki H, Wilde-Smith C. Do continuous infusions of omeprazole retai n there effect with prolonged dosing[J] Gastroenterology, 1994,106:60.
  • 4[5] Lind T, Adland E, Eriksson P, et al. Benefical effects of i.v. omepra zole in patients with peptic ulcer bleeding[J]. Gastroenterology, 1995,108:49.
  • 5Richter JE, Kahrilas PJ.Johanson J,Maton P, Breiter JR, Hwang C et al.Efficacy and safety of esomeprazole compared with omeprazole in GERD patients with erosive esophagitis:a randomized controlled trial,Am J Gastroenterol 2001;96:656-65.
  • 6Tulassay Z,Kryszewski A,Dite P,Kleczkowiski D,Rudzinski J,Bartuzi Z et al.One week treatment with es-omeprazole -based triple herapy eradicates H.pylori and heals patients with duodenal ulcer disease. Eur J Gastroenterol Hepatol 2001.
  • 7北京国产奥美拉唑针剂研究协作组,杨昭徐.国产奥美拉唑针剂对非食管静脉曲张破裂出血的临床观察[J].中华内科杂志,1999,38(7):478-480. 被引量:23
  • 8唐永沐,刘友松,魏美荣.奥美拉唑治疗消化性溃疡疗效观察[J].中国现代医学杂志,2000,10(5):99-99. 被引量:6
  • 9姚光弼.质子泵抑制剂的新成员——埃索美拉唑[J].中华消化杂志,2002,22(4):233-235. 被引量:56

共引文献26

同被引文献117

引证文献16

二级引证文献123

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部